Application of angiogenic factors for therapy of erectile dysfunction: Protein and DNA transfer of VEGF 165 into the rat penis

Urology

Volumn 66, Issue 3, 2005, Pages 665-670

  Burchardt, Martin ^b   Burchardt, Tatjana ^b   Anastasiadis, Aristotelis G ^b   Buttyan, Ralph ^b   De La Taille, Alexandre ^b   Shabsigh, Ahmad ^b   Frank, Jorge ^b   Shabsigh, Ridwan ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; LIPOSOME; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DNA TRANSFECTION; DNA TRANSFER; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; EXPRESSION VECTOR; IMMUNOASSAY; MALE; NONHUMAN; OSMOTIC PUMP; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RENAL ARTERY; SMOOTH MUSCLE; STATISTICAL ANALYSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; DRUG CARRIERS; GENE THERAPY; IMPOTENCE; MALE; MICROINJECTIONS; PENIS; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24144464544     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.03.058     Document Type: Article

References (27)

1. NIH Consensus Development Panel on Impotence NIH consensus conference impotence JAMA 270 1993 83 90
2. I.A. Aytaç, J.B. McKinlay, R.J. Krane The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences BJU Int 84 1999 50 56
3. H.A. Feldman, I. Goldstein, D.G. Hatzichristou Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
4. T.F. Lue Erectile dysfunction N Engl J Med 342 2000 1802 1813
5. G.J. Christ, J. Rehman, N. Day Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function Am J Physiol 275 1998 H600 H608
6. H. Garban, D. Marquez, T. Magee Cloning of rat and human inducible penile nitric oxide synthase application for gene therapy of erectile dysfunction Biol Reprod 56 1997 954 963
7. N. Ferrara, T. Davis-Smith The biology of vascular endothelial growth factor Endocr Rev 18 1997 4 25
8. J.D. Hood, C.J. Meininger, M. Ziche VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells Am J Physiol 274 1998 H1054 H1058
9. R. van der Zee, T. Murohara, Z. Luo Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium Circulation 95 1997 1030 1037
10. S. Takeshita, L.P. Zheng, E. Brogi Therapeutic angiogenesis a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model J Clin Invest 93 1994 662 670
11. M.D. Hariawala, J.R. Horowitz, D. Esakof VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts J Surg Res 63 1996 77 82
12. K. Harada, M. Friedman, J.J. Lopez Vascular endothelial growth factor administration in chronic myocardial ischemia Am J Physiol 270 1996 H1791 H1802
13. G.D. Henry, R. Byrne, T.T. Hunyh Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit a preliminary study Int J Impot Res 12 2000 334 339
14. R.R. Byrne, G.D. Henry, D.S. Rao Vascular endothelial growth factor restores corporeal smooth muscle function in vitro J Urol 165 2001 1310 1315
15. X. Liu, C.S. Lin, T. Graziottin Vascular endothelial growth factor promotes proliferation and migration of cavernous smooth muscle cells J Urol 166 2001 354 360
16. C.S. Lin, H.C. Ho, K.C. Chen Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms BJU Int 89 2002 955 960
17. R.S. Rogers, T.M. Graziottin, C.S. Lin Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats Int J Impot Res 15 2003 26 37
18. S.S. Gholami, R. Rogers, J. Chang The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia J Urol 169 2003 1577 1581
19. G.D. Yancopoulos, S. Davis, N.W. Gale Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
20. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395
21. M. Burchardt, T. Burchardt, M.W. Chen Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans Biol Reprod 60 1999 398 404
22. T. Burchardt, M. Burchardt, J. Karden Reduction of endothelial cell and smooth muscle density in the corpora cavernosa of the streptozotocin-induced diabetic rat J Urol 164 2000 1807 1811
23. T. Asahara, C. Bauters, C. Pastore Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery Circulation 91 1995 2793 2801
24. T. Burchardt, M. Burchardt, M.W. Chen Expression of VEGF splice variants 144/145 and 205/206 in adult male tissues IUBMB Life 48 1999 405 408
25. M.C. Lee, A.I. El-Sakka, T.M. Graziottin The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction J Urol 167 2002 761 767
26. T.D. Henry, B.H. Annex, G.R. McKendall The VIVA trial vascular endothelial growth factor in ischemia for vascular angiogenesis Circulation 107 2003 1359 1365
27. J. Kastrup Therapeutic angiogenesis in ischemic heart disease gene or recombinant vascular growth factor protein therapy? Curr Gene Ther 3 2003 197 206